Analyst firms RBC and Morgan Stanley set price targets for OTIS, with MarketBeat aggregating the ratings.
5 reports, 2 independent
Updated Nov 1
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firms RBC and Morgan Stanley set price targets for OTIS, with MarketBeat aggregating the ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
OTIS
American elevator and escalator manufacturer
-
Royal Bank of Canada
financial institution in Canada
-
Morgan Stanley
U.S. investment bank
Related events
- MarketBeat reports consensus ratings from sixteen brokerages, including RBC's 'outperform' rating and Scotiabank's target price cut for Lightspeed.
- Royal Bank of Canada dropped its price target for Fiverr International from $16.00 to $9.00, with MarketBeat aggregating the rating.
- MarketBeat, Royal Bank of Canada, and Raymond James Financial updated their ratings and price targets for CT Real Estate Investment Trust.
- MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
- RBC and Citigroup boosted price objectives on Lockheed Martin shares, with MarketBeat aggregating the analyst ratings.